1. Home
  2. CHCO vs ARQT Comparison

CHCO vs ARQT Comparison

Compare CHCO & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • ARQT
  • Stock Information
  • Founded
  • CHCO 1957
  • ARQT 2016
  • Country
  • CHCO United States
  • ARQT United States
  • Employees
  • CHCO N/A
  • ARQT N/A
  • Industry
  • CHCO Major Banks
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • ARQT Health Care
  • Exchange
  • CHCO Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • CHCO 1.8B
  • ARQT 2.1B
  • IPO Year
  • CHCO N/A
  • ARQT 2020
  • Fundamental
  • Price
  • CHCO $124.28
  • ARQT $17.67
  • Analyst Decision
  • CHCO Hold
  • ARQT Strong Buy
  • Analyst Count
  • CHCO 3
  • ARQT 7
  • Target Price
  • CHCO $132.33
  • ARQT $19.00
  • AVG Volume (30 Days)
  • CHCO 77.6K
  • ARQT 1.5M
  • Earning Date
  • CHCO 10-23-2025
  • ARQT 11-05-2025
  • Dividend Yield
  • CHCO 2.54%
  • ARQT N/A
  • EPS Growth
  • CHCO 6.95
  • ARQT N/A
  • EPS
  • CHCO 8.30
  • ARQT N/A
  • Revenue
  • CHCO $300,872,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • CHCO $9.69
  • ARQT $72.46
  • Revenue Next Year
  • CHCO $1.71
  • ARQT $31.69
  • P/E Ratio
  • CHCO $14.96
  • ARQT N/A
  • Revenue Growth
  • CHCO 4.61
  • ARQT 99.50
  • 52 Week Low
  • CHCO $102.22
  • ARQT $8.03
  • 52 Week High
  • CHCO $137.28
  • ARQT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 43.24
  • ARQT 59.14
  • Support Level
  • CHCO $122.22
  • ARQT $16.62
  • Resistance Level
  • CHCO $126.98
  • ARQT $18.15
  • Average True Range (ATR)
  • CHCO 2.40
  • ARQT 0.69
  • MACD
  • CHCO -0.66
  • ARQT 0.01
  • Stochastic Oscillator
  • CHCO 20.29
  • ARQT 66.89

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: